2,899 hedge funds and large institutions have $109B invested in Pfizer in 2024 Q3 according to their latest regulatory filings, with 190 funds opening new positions, 1,240 increasing their positions, 1,193 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

4% more capital invested

Capital invested by funds: $105B → $109B (+$3.82B)

0.38% more ownership

Funds ownership: 65.94%66.31% (+0.38%)

38% less call options, than puts

Call options by funds: $2.51B | Put options by funds: $4.05B

Holders
2,899
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
42
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.51B
Puts
$4.05B
Net Calls
Net Calls Change

Top Buyers

1 +$425M
2 +$375M
3 +$345M
4
BlackRock
BlackRock
New York
+$339M
5
Deutsche Bank
Deutsche Bank
Germany
+$286M

Top Sellers

1 -$1.01B
2 -$360M
3 -$265M
4
Franklin Resources
Franklin Resources
California
-$262M
5
DCP
D1 Capital Partners
New York
-$213M
Name Holding Trade Value Shares
Change
Change in
Stake
276
$22.8M
277
$22.7M
278
$22.6M
279
$22.6M
280
$22.5M
281
$22.5M
282
$22.3M
283
$22.1M
284
$21.9M
285
$21.8M
286
$21.8M
287
$21.7M
288
$21.6M
289
$21.5M
290
$21.4M
291
$21.4M
292
$21.2M
293
$21.1M
294
$20.9M
295
$20.7M
296
$20.4M
297
$20.4M
298
$20.2M
299
$20.2M
300
$20.1M